Lipid metabolome-wide effects of the PPARγ agonist rosiglitazone
Open Access
- 1 November 2002
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 43 (11) , 1809-1817
- https://doi.org/10.1194/jlr.m200169-jlr200
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Diabetic KKAy mice exhibit increased hepatic PPARγ1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinedionesPublished by Elsevier ,2001
- Unique phospholipid metabolism in mouse heart in response to dietary docosahexaenoic or α‐linolenic acidsLipids, 2001
- Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitusExperimental and Clinical Endocrinology & Diabetes, 2000
- Troglitazone action is independent of adipose tissue.Journal of Clinical Investigation, 1997
- Suppression of hepatic gluconeogenesis in long-term troglitazone treated diabetic KK and miceMetabolism, 1995
- Omega-3 fatty acids and prevention of ventricular fibrillationProstaglandins, Leukotrienes & Essential Fatty Acids, 1995
- Long-term dietary fish oil supplementation protects against ischemia-reperfusion-induced myocardial dysfunction in isolated rat heartsAmerican Heart Journal, 1993
- Cardiolipins and biomembrane functionBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1992
- Role of cardiolipin in the functioning of mitochonbrial L-glycerol-3-phosphate dehydrogenaseBiochemical and Biophysical Research Communications, 1989
- Lipids of mitochondriaBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1985